Holen Sie sich die Stockscreener-App
2.08
8.33%
0.16
Vorhandelsmarkt:
2.09
0.010
+0.48%
Schlusskurs vom Vortag:
$1.92
Offen:
$1.93
24-Stunden-Volumen:
715.18K
Relative Volume:
1.32
Marktkapitalisierung:
$147.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.50M
KGV:
-0.8667
EPS:
-2.4
Netto-Cashflow:
$-114.31M
1W Leistung:
+14.29%
1M Leistung:
+17.51%
6M Leistung:
-16.13%
1J Leistung:
-67.85%
1-Tages-Spanne:
$1.91
$2.10
1-Wochen-Bereich:
$1.78
$2.10
52-Wochen-Spanne:
$1.31
$7.24
Nkarta Inc Stock (NKTX) Company Profile
Firmenname
Nkarta Inc
Sektor
Branche
Telefon
(925) 407-1049
Adresse
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Vergleichen Sie NKTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.08 | 129.14M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-09 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-08-14 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-07-28 | Eingeleitet | Needham | Buy |
| 2022-07-18 | Eingeleitet | SVB Leerink | Outperform |
| 2022-03-11 | Eingeleitet | Raymond James | Outperform |
| 2022-03-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-06 | Eingeleitet | William Blair | Outperform |
| 2021-11-18 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2020-08-04 | Eingeleitet | Cowen | Outperform |
| 2020-08-04 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-04 | Eingeleitet | Mizuho | Buy |
| 2020-08-04 | Eingeleitet | Stifel | Buy |
Alle ansehen
Nkarta Inc Aktie (NKTX) Neueste Nachrichten
What analysts say about Nkarta Inc. stockSuperior portfolio returns - Autocar Professional
Is Nkarta Inc. a good long term investmentFree Technical Analysis Support - Autocar Professional
What drives Nkarta Inc. stock priceExceptional risk-adjusted gains - jammulinksnews.com
How Nkarta Inc. stock performs during market volatilityFree Consultation - Newser
Nkarta: Holding Its Support Steady Ahead Of First Data Readouts In 2025 - Seeking Alpha
Nkarta Inc. Stock Analysis and ForecastExceptional profit margins - jammulinksnews.com
Why Nkarta Inc. stock attracts strong analyst attentionInsider Strategy Insight - Newser
What makes Nkarta Inc. stock price move sharplyFree Elite Traders Group - Newser
17,365 Shares in Nkarta, Inc. (NASDAQ:NKTX) Acquired by Wealth Enhancement Advisory Services LLC - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Given Average Recommendation of “Buy” by Brokerages - Defense World
Nkarta (NASDAQ:NKTX) Stock Price Up 3% – Here’s What Happened - Defense World
Nkarta (NASDAQ:NKTX) Price Target Lowered to $14.00 at Mizuho - Defense World
Nkarta (NKTX) Maintains Outperform Rating as Mizuho Lowers Price Target | NKTX Stock News - GuruFocus
Two Sigma Investments LP Reduces Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta price target lowered to $14 from $16 at Mizuho - TipRanks
Nkarta (NKTX) Price Target Reduced by Mizuho | NKTX Stock News - GuruFocus
Nkarta, Inc. (NASDAQ:NKTX) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Wellington Management Group LLP - Defense World
Bank of America Corp DE Grows Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Two Sigma Advisers LP Acquires New Stake in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta Names Shawn Rose as Chief Medical Officer - marketscreener.com
Nkarta Announces Leadership Change with New CMO - TipRanks
NKTX Appoints Shawn Rose as New Chief Medical Officer | NKTX Stock News - GuruFocus
Nkarta appoints Shawn Rose as CMO, head of R&D - TipRanks
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of - GlobeNewswire
Nkarta Taps Sotyktu, Stelara Developer as New CMO to Lead Autoimmune Disease Push - Stock Titan
Nkarta, Inc. (NASDAQ:NKTX) Shares Bought by Nuveen Asset Management LLC - Defense World
ProShare Advisors LLC Invests $45,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Deutsche Bank AG Has $107,000 Stock Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Millennium Management LLC Boosts Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
BNP Paribas Financial Markets Invests $507,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta (NKTX) Moves to Buy: Rationale Behind the Upgrade - MSN
Equities Analysts Issue Forecasts for Nkarta FY2025 Earnings - Defense World
Leerink Partnrs Analysts Lower Earnings Estimates for Nkarta - Defense World
Price T Rowe Associates Inc. MD Acquires 7,030 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
William Blair Comments on Nkarta’s Q2 Earnings (NASDAQ:NKTX) - Defense World
Nkarta (NASDAQ:NKTX) Earns “Market Perform” Rating from William Blair - Defense World
Needham & Company LLC Lowers Nkarta (NASDAQ:NKTX) Price Target to $10.00 - Defense World
Finanzdaten der Nkarta Inc-Aktie (NKTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):